Comparative Pharmacology
Head-to-head clinical analysis: COBAVITE versus HYDROXOMIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COBAVITE versus HYDROXOMIN.
COBAVITE vs HYDROXOMIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cobavite is a combination of vitamin B12 and intrinsic factor; vitamin B12 is essential for DNA synthesis, hematopoiesis, and neurological function. Intrinsic factor facilitates the absorption of vitamin B12 in the ileum.
Hydroxocobalamin is a synthetic form of vitamin B12 that acts as a cofactor for methionine synthase and methylmalonyl-CoA mutase, essential for DNA synthesis, myelin formation, and hematopoiesis. It also acts as a direct scavenger of cyanide ions by binding to them to form cyanocobalamin, which is excreted renally.
1.5 mg/kg IV every 12 hours
100 mg intramuscularly or deep subcutaneously three times a week.
None Documented
None Documented
Terminal half-life 12-15 hours in healthy adults; prolonged to 24-30 hours in severe renal impairment (CrCl <30 mL/min).
Terminal elimination half-life approximately 4-6 hours; may extend to 8-12 hours in moderate to severe renal impairment (CrCl <30 mL/min).
Renal excretion of unchanged drug 60-70%; biliary/fecal elimination 20-30%; minor hepatic metabolism.
Primarily renal (80-90% unchanged) with minor biliary/fecal elimination (5-10%); total clearance ~150 mL/min.
Category C
Category C
Vitamin B12 Supplement
Vitamin B12 Supplement